Fasiglifam，TAK-875

Chemical Name:

(S)-2-(6-((2',6'-dimethyl-4'-(3-(methylsulfonyl)propoxy)-[1,1'-biphenyl]-3-yl)methoxy)-2,3-dihydrobenzofuran-3-yl)acetic acid

SMILES Code: 

O=C(O)C[C@@H]1COC2=CC(OCC3=CC(C4=C(C)C=C(OCCCS(=O)(C)=O)C=C4C)=CC=C3)=CC=C12

InChi Code:

InChI=1S/C29H32O7S/c1-19-12-25(34-10-5-11-37(3,32)33)13-20(2)29(19)22-7-4-6-21(14-22)17-35-24-8-9-26-23(15-28(30)31)18-36-27(26)16-24/h4,6-9,12-14,16,23H,5,10-11,15,17-18H2,1-3H3,(H,30,31)/t23-/m1/s1

InChi Key:

BZCALJIHZVNMGJ-HSZRJFAPSA-N

Keyword:

1000413-72-8；CAS:1000413-72-8；CAS：1000413-72-8；TAK875；TAK-875；TAK 875；Fasiglifam

Solubility: Soluble in DMSO, not in water

Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

Description: 

Fasiglifam (TAK-875) is an effective, oral, and selective GPR40 agonist.

Target: GPR40 agonist